Economic evaluation of quality improvement interventions for bloodstream infections related to central catheters: A systematic review

JAMA Internal Medicine

Volumn 176, Issue 12, 2016, Pages 1843-1854

  Nuckols, Teryl K ^a,b   Keeler, Emmett ^b   Morton, Sally C ^c   Anderson, Laura ^a,d   Doyle, Brian ^e   Booth, Marika ^b   Shanman, Roberta ^b   Grein, Jonathan ^a   Shekelle, Paul ^b,e  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b RAND CORPORATION   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER INFECTION; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMERGENCY CARE; HEALTH CARE COST; HUMAN; INCIDENCE; MEDLINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; ADVERSE EFFECTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETER; CHECKLIST; COST BENEFIT ANALYSIS; ECONOMICS; INFECTION CONTROL; PROCEDURES; PROGRAM EVALUATION;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CHECKLIST; COST-BENEFIT ANALYSIS; HUMANS; INFECTION CONTROL; PROGRAM EVALUATION; QUALITY IMPROVEMENT;

EID: 85011263984     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.6610     Document Type: Review

References (77)

1. 2012 National and State Healthcare-Associated Infections Progress Report. Atlanta, GA: Centers for Disease Control and Prevention; March 26, 2014.
2. Magill SS, Edwards JR, BambergW, et al; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-1208.
3. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: ameta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046.
4. Shekelle PG,Wachter RM, Pronovost PJ, et al Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices. Rockville, MD: Agency for Healthcare Research and Quality; March 2013.
5. Etchells E, KooM, Daneman N, et al. Comparative economic analyses of patient safety improvement strategies in acute care: A systematic review. BMJ Qual Saf. 2012;21(6):448-456.
6. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477-2481.
7. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097.
8. Nuckols T, Maglione M, Shekelle P, Morton S, Escarce J, Keeler E. Systematic review of cost outcomes of quality improvement. PROSPERO. 2015;CRD42015014950. http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID =CRD42015014950. Accessed May 1, 2016.
9. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011.Washington, D.C.: US Department of Health & Human Services, Centers for Disease Control; 2011.
10. Chen X-X, Lo Y-C, Su L-H, Chang C-L. Investigation of the case numbers of catheter-related bloodstream infection overestimated by the central line-associated bloodstream infection surveillance definition. J Microbiol Immunol Infect. 2015;48(6):625-631.
11. Glanville J, Kaunelis D, Mensinkai S. How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE. Int J Technol Assess Health Care. 2009;25(4):522-529.
12. Infectious Diseases Society of America. IDSA Archived Conference Presentations. 2016; https://idsa.confex.com/idsa/archives.cgi. Accessed August 2, 2016.
13. Mauger Rothenberg B, Marbella A, Pines E, Chopra R, Black ER, Aronson N. Closing the quality gap: revisiting the state of the science (vol. 6: prevention of healthcare-associated infections). Evid Rep Technol Assess (Full Rep). 2012;Nov (208.6):1-578.
14. Ranji SR, Shetty K, Posley KA, et al. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 6: Prevention of Healthcare-Associated Infections). Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan. (Technical Reviews, No. 9.6.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK43982/.
15. Ho KM, Litton E. Use of chlorhexidineimpregnated dressing to prevent vascular and epidural catheter colonization and infection: ameta-analysis. J Antimicrob Chemother. 2006;58 (2):281-287.
16. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101-114.
17. Flodgren G, Conterno LO,Mayhew A, Omar O, Pereira CR, Shepperd S. Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev. 2013;3(3):CD006559.
18. Goeree R, Burke N, O'Reilly D, Manca A, Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23(4): 671-682.
19. Danz MS, Rubenstein LV, Hempel S, et al. Identifying quality improvement intervention evaluations: is consensus achievable? Qual Saf Health Care. 2010;19(4):279-283.
20. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
21. Cochrane Consumers & Communication Review Group Study Design Guide For Review Authors; The Cochrane Collaboration. June 2013:1-56. http://cccrg.cochrane.org/sites/cccrg.cochrane.org/files/uploads/Study-design-guide2013.pdf.
22. Hempel S, Shekelle PG, Liu JL, et al. Development of the Quality Improvement Minimum Quality Criteria Set (QI-MQCS): A tool for critical appraisal of quality improvement intervention publications. BMJ Qual Saf. 2015; 24(12):796-804.
23. Nuckols TK, Escarce JJ, Asch SM. The effects of quality of care on costs: A conceptual framework. Milbank Q. 2013;91(2):316-353.
24. Chiou CF, Hay JW,Wallace JF, et al. Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003;41(1):32-44.
25. Walker DG, Wilson RF, Sharma R, et al. Best Practices for Conducting Economic Evaluations in Health Care: A Systematic Review of Quality Assessment Tools [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Oct. https://www.ncbi.nlm.nih.gov/books/NBK114545/
26. Gold MR, Siegel JE, Russell LB,Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
27. Allen GB, Miller V, Nicholas C, et al. A multitiered strategy of simulation training, kit consolidation, and electronic documentation is associated with a reduction in central line-associated bloodstream infections. Am J Infect Control. 2014;42(6):643-648.
28. Anderson DJ, Miller BA, Chen LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol. 2011;32(4):315-322.
29. Bond WF, King AE. Modeling for the decision process to implement an educational intervention: an example of a central venous catheter insertion course. J Patient Saf. 2011;7(2):85-91.
30. Burden AR, Torjman MC, Dy GE, et al. Prevention of central venous catheter-related bloodstream infections: is it time to add simulation training to the prevention bundle? J Clin Anesth. 2012;24(7):555-560.
31. Cohen ER, Feinglass J, Barsuk JH, et al. Cost savings from reduced catheter-related bloodstream infection after simulation-based education for residents in a medical intensive care unit. Simul Healthc. 2010;5(2):98-102.
32. Cooper K, Frampton G, Harris P, et al. Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective? J Hosp Infect. 2014;86(1):47-52.
33. Deutsch GB, Sathyanarayana SA, Singh N, Nicastro J. Ultrasound-guided placement of midline catheters in the surgical intensive care unit: A cost-effective proposal for timely central line removal. J Surg Res. 2014;191(1):1-5.
34. Fraher MH, Collins CJ, Bourke J, Phelan D, Lynch M. Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections. J Hosp Infect. 2009;73(2):129-134.
35. Frankel HL, Crede WB, Topal JE, Roumanis SA, DevlinMW, Foley AB. Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU. J AmColl Surg. 2005; 201(3):349-358.
36. Herzer KR, Niessen L, Constenla DO,WardWJ Jr, Pronovost PJ. Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. BMJ Open. 2014;4(9): e006065.
37. Kagan RJ, Neely AN, Rieman MT, et al. A performance improvement initiative to determine the impact of increasing the time interval between changing centrally placed intravascular catheters. J Burn Care Res. 2014;35 (2):143-147.
38. Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control. 2011;39(8):640-646.
39. Miller MR, Niedner MF, HuskinsWC, et al; National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation Teams. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011;128(5):e1077-e1083.
40. Waters HR, Korn R Jr, Colantuoni E, et al. The business case for quality: economic analysis of the Michigan Keystone Patient Safety Program in ICUs. Am J Med Qual. 2011;26(5):333-339.
41. Dick AW, Perencevich EN, Pogorzelska-Maziarz M, Zwanziger J, Larson EL, Stone PW. A decade of investment in infection prevention: A cost-effectiveness analysis. Am J Infect Control. 2015;43(1):4-9.
42. Kamboj M, Blair R, Bell N, et al. Use of disinfection cap to reduce central-line-associated bloodstream infection and blood culture contamination among hematology-oncology patients. Infect Control Hosp Epidemiol. 2015;36 (12):1401-1408.
43. Pfaff B, Heithaus T, Emanuelsen M. Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients. Crit Care Nurse. 2012;32(4):35-40.
44. Ye X, RupnowM, Bastide P, Lafuma A, Ovington L, Jarvis WR. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control. 2011;39(8): 647-654.
45. Halton KA, Cook DA, WhitbyM, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care. 2009;13(2):R35.
46. Borschel DM, Chenoweth CE, Kaufman SR, et al. Are antiseptic-coated central venous catheters effective in a real-world setting? Am J Infect Control. 2006;34(6):388-393.
47. Hu KK, Veenstra DL, Lipsky BA, Saint S. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis. 2004;39(10):1441-1445.
48. Crawford AG, Fuhr JP Jr, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004;25 (8):668-674.
49. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: The clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis. 2003;37(6):764-771.
50. Hanna HA, Raad II, Hackett B, et al; M.D. Anderson Catheter Study Group. Antibioticimpregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest. 2003;124 (3):1030-1038.
51. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: potential financial implications. Chest. 2003;124(1):275-284.
52. Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control. 2003;31(1):1-8.
53. Schwebel C, Lucet JC, Vesin A, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40(1):11-17.
54. Nelson RE, Angelovic AW, Nelson SD, Gleed JR, Drews FA. An economic analysis of adherence engineering to improve use of best practices during central line maintenance procedures. Infect Control Hosp Epidemiol. 2015;36(5):550-556.
55. Stango C, Runyan D, Stern J, Macri I, Vacca M. A successful approach to reducing bloodstream infections based on a disinfection device for intravenous needleless connector hubs. Nurs Res Pract. 2014;37(6):462-465.
56. Merrill KC, Sumner S, Linford L, Taylor C, Macintosh C. Impact of universal disinfectant cap implementation on central line-associated bloodstream infections. Am J Infect Control. 2014; 42(12):1274-1277.
57. Yokoe DS, Anderson DJ, Barenholtz SM, et al. Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals: 2014 Updates. Infect Control Hosp Epidemiol. 2014; 35(8):967-977.
58. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65(suppl 1):S1-S64.
59. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23(12):759-769.
60. Pronovost PJ, Berenholtz SM, Goeschel C, et al. Improving patient safety in intensive care units in Michigan. J Crit Care. 2008;23(2):207-221.
61. Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: A model for large scale knowledge translation. BMJ. 2008;337:a1714.
62. Miller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010;125(2):206-213.
63. Krein SL, Fowler KE, Ratz D, Meddings J, Saint S. Preventing device-associated infections in US hospitals: national surveys from 2005 to 2013. BMJ Qual Saf. 2015;24(6):385-392. Accessed February 18, 2016.
64. Ista E, van der Hoven B, Kornelisse RF, et al. Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: A systematic review and meta-analysis. Lancet Infect Dis. 2016;16(6):724-734. Epub ahead of print.
65. Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D. Prevention of central line-associated bloodstream infections through quality improvement interventions: A systematic review and meta-analysis. Clin Infect Dis. 2014;59(1):96-105.
66. Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, US Department of Health and Human Services. National Action Plan To Prevent Health Care-Associated Infections: Road Map To Elimination. Part 2: Framework. April 2013; http://www.health.gov/hai/pdfs/hai-action-plan-framework.pdf. Accessed May 19, 2016.
67. Centers for Medicare & Medicaid Services. Partnership for Patients. 2015; http://innovation .cms.gov/initiatives/partnership-for-patients/. Accessed May 19, 2016.
68. Interim Update on 2013 Annual Hospital-Acquired Condition Rate and Estimates of Cost Savings and Deaths Averted From 2010 to 2013. Washington, D.C.: Health and Human Services; 2014.
69. Prepared by Andrew Clarkwest PD. Arnold Chen MD, Maureen Higgins, et al. Project Evaluation Activity in Support of Partnership for Patients: Task 2 Evaluation Progress Report. Baltimore, MD: Center for Medicare and Medicaid Innovation; 2014.
70. Centers for Medicare & Medicaid Services. Hospital Value-Based Purchasing. 2012; https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html?redirect=/Hospital-Value-Based-Purchasing/. Accessed May 19, 2016.
71. Rajaram R, Barnard C, Bilimoria KY. Concerns about using the patient safety indicator-90 composite in pay-for-performance programs. JAMA. 2015;313(9):897-898.
72. Centers for Medicare & Medicaid Services. Hospital-Acquired Conditions. 2015; http://www .cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/Hospital-Acquired-Conditions.html. Accessed May 19, 2016.
73. Centers for Medicare & Medicaid Services. Hospital-Acquired Condition Reduction Program (HACRP). 2014; https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/HAC-Reduction-Program.html. Accessed May 19, 2016.
74. Dudeck MA, Edwards JR, Allen-Bridson K, et al. National Healthcare Safety Network report, data summary for 2013, Device-associated Module. Am J Infect Control. 2015;43(3):206-221.
75. Weiner LM, Fridkin SK, Aponte-Torres Z, et al. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals-United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(9):235-241.
76. Avalere Health for the American Hospital Association. American Hospital Association Trendwatch Chartbook 2015: Trends Affecting Hospitals and Health Systems. 2015; http://www .aha.org/research/reports/tw/chartbook/ch4.shtml. Accessed May 19, 2016.
77. Pratt WR. What does free cash flow tell us about hospital efficiency? A stochastic frontier analysis of cost inefficiency in California hospitals. J Health Care Finance. 2010;37(1):35-44.